1Chow LW,Loo WT.The differential effects of cyclophosphamide,epirubicin and 5-fluorouracil on apoptotic marker(CPP-32),pro-apoptotic protein[p21(WAF-1)] and anti-apoptotic protein(bcl-2) in breast cancer cells[J].Breast Cancer Res Treat,2003,80(3):239-244.
2Stern M,Herrmann R.Overview of monoclonal antibodies in cancer therapy:present and promise[J].Crit Rev Oncol Hematol,2005,54(1):11-29.
3Mehra R,Burtness B.Antibody therapy for early-stage breast cancer:trastuzumab adjuvant and neoadjuvant trials[J].Expert Opin Biol Ther,2006,6(9):951-962.
4Yardley DA.Activity of ixabepilone in patients with metastatic breast cancer with primary resestance to taxanes[J].Clin Breast Cancer,2008,8(6):487-492.
6Osoba D, Slamon D J, Burchmore M, et al. Effects on quality of life of combined trastuzumab and chemotherapy in women with metastatic breast cancer[ J]. J Clin Oncol, 2002, 20(14): 3106-3113.
